Case Summary:

Our esteemed client from China came to us seeking help with his EB1A (Alien of Extraordinary Ability) application. We were able to not only draft and file his petition, help him through the process, and answer his questions, but we also were able to get his application approved in only 9 days without an RFE (request for additional evidence)! Only because of his application, which included his professional and academic transcripts and highlighted his remarkable accomplishments, was this feasible. His specific petition, in particular, mentioned his peer reviews, academic writings, prominent responsibilities, and creative contributions. Below are the specifics of the same:

• The postdoctoral fellow has held leading and critical roles in organizations with distinguished reputations in the U.S. He has conducted extensive research and authored 27 peer-reviewed scientific articles which he published in some of the most professional journals. His research was cited 1,128 times by researchers in at least 51 countries according to Google Scholar, thereby confirming that these publications are widely recognized and relied upon in the field of neuroscience.
• He has also served as a reviewer for journal articles and conducted at least 60 peer reviews for highly acclaimed journals. In addition, he met this requirement even more because he was a guest editor on the biology editorial board. The AAO has found that evidence proving a petitioner has been on an editorial board also proves the petitioner has been a judge of other people’s work. These statements and related objective evidence prove our client’s active and actual participation as a judge of the work of other experts in the field.

Moreover, we emphasized the unique contributions that our client has made to the field of neuroscience. Some of the most urgent problems facing our country and the globe now are addressed by his low-level laser therapy, neuron-derived estrogen, and exercise therapy for Alzheimer’s disease studies. These include the increased incidence of neurological illnesses and neurodegenerative disorders.

We discussed further how his groundbreaking research has received funding from the National Institute of Neurological Disorders and Stroke and the American Heart Association. This funding supports projects that reduce the burden of conditions like heart disease and neurological disease. Therefore, our client’s research establishes low-level laser therapy as an effective treatment method for a wide variety of conditions.

He is more than capable of carrying on his work in the United States and expanding his knowledge and influence in his area of specialization. 9 days later, we were ecstatic to obtain his EB1A APPROVAL, not surprised at all given his enormous contributions. We are honored to represent individuals such as him, and we look forward to continuing our relationship and following his future successes.